Filing Details

Accession Number:
0000947871-14-000528
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-14 19:38:12
Reporting Period:
2014-08-12
Filing Date:
2014-08-14
Accepted Time:
2014-08-14 19:38:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326583 Webmd Health Corp. WBMD Services-Business Services, Nec (7389) 202783228
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
905448 J Martin Wygod C/O Webmd Health Corp.
111 Eighth Avenue
New York NY 10011
Chairman Of The Board Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-08-12 180,000 $23.61 382,219 No 4 M Direct
Common Stock Disposition 2014-08-12 136,210 $48.06 246,009 No 4 F Direct
Common Stock Disposition 2014-08-12 40,630 $47.93 205,379 No 4 S Direct
Common Stock Acquisiton 2014-08-13 175,000 $29.44 380,379 No 4 M Direct
Common Stock Disposition 2014-08-13 142,584 $48.06 237,795 No 4 F Direct
Common Stock Disposition 2014-08-13 53,789 $47.84 184,006 No 4 S Direct
Common Stock Disposition 2014-08-14 20,500 $47.79 163,506 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-08-12 180,000 $0.00 180,000 $23.61
Common Stock Stock Option (Right to Buy) Disposition 2014-08-13 175,000 $0.00 175,000 $29.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-12-10 No 4 M Direct
175,000 2021-09-25 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 837,758 Indirect By Trust
Common Stock 2,222 Indirect By Spouse
Common Stock 26,146 Indirect By SYNC, Inc.
Common Stock 105 Indirect By 401(k) Plan
Footnotes
  1. Mr. Wygod received 43,790 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 180,000 shares of WebMD Common Stock, with the remaining 136,210 shares being retained by the issuer to pay the exercise price and to satisfy the minimum tax withholding requirements arising from the exercise.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.63 to $48.04 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
  3. Mr. Wygod received 32,416 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 175,000 shares of WebMD Common Stock, with the remaining 142,584 shares being retained by the issuer to pay the exercise price and to satisfy the minimum tax withholding requirements arising from the exercise.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.62 to $48.16 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.09 to $47.87 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4.
  6. 25% of the shares underlying the option vested on each of 3/31/2010, 3/31/2011, 3/31/2012 and 3/31/2013 (fully vested on 3/31/2013). The date of grant for the options was ten years prior to the expiration date.
  7. 25% of the shares underlying the option vest on each of the first, second, third and fourth anniversaries of the grant date (fully vested on the 4th anniversary of the grant date). The date of grant for the options was ten years prior to the expiration date.